Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation-Reference-Cited by-同舟云学术

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

Published:2019-09-04 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Valembois Lucie¹,Audureau Etienne²,Takeda Andrea³,Jarzebowski Witold⁴,Belmin Joël⁵,Lafuente-Lafuente Carmelo¹

Affiliation:

1. Groupe Hospitalier Pitié-Salpêtrière-Charles Foix, AP-HP, Université Pierre et Marie Curie; Service de Gériatrie à Orientation Cardiologique et Neurologique; 7 avenue de la République Ivry-sur-Seine France 94200

2. Hôpital Henri-Mondor, APHP, Université Paris 12 UPEC; Service de Santé Publique; 51 Avenue du Maréchal de Lattre de Tassigny Créteil France 94010

3. University College London; Institute of Health Informatics Research; London UK

4. Centre Hospitalier de Bastia; Court Séjour Gériatrique; Bastia France

5. Université Pierre et Marie Curie (Paris 6); La Triade - Service Hospitalo-Universitaire de Gérontologie; Group Hospitalier Pitié-Salpêtrière-Charles Foix 7, Avenue de la République, 94 Ivry-sur-Seine Paris France

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005049.pub5/epdf/full

Reference263 articles.

1. Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm;Pritchett;American Heart Journal,2006

2. Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial;Lombardi;European Heart Journal,2006

3. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug;AFFIRM First Antiarrhythmic Drug Substudy Investigators;Journal of the American College of Cardiology,2003

4. Treatment of atrial fibrillation and paroxysmal supraventricular tachycardia with bidisomide;The Atrial Fibrillation Investigation with Bidisomide (AFIB) Investigators;Circulation,1997

5. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter;Aliot;American Journal of Cardiology,1996

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of flecainide for cardiac arrhythmias: a short review of studies and clinical recommendations;Journal of Arrhythmology;2024-08-22

2. Body surface mapping of P-waves in sinus rhythm to predict recurrence following cardioversion for atrial fibrillation;Frontiers in Cardiovascular Medicine;2024-07-25

3. Antiarrhythmic preferences and outcomes post DC cardioversion for atrial fibrillation, an Australian rural perspective;Australian Journal of Rural Health;2024-05-20

4. 2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary;Thrombosis and Haemostasis;2024-05-14

5. Chinese guidelines for the diagnosis and management of atrial fibrillation;Pacing and Clinical Electrophysiology;2024-04-30